Form 4 for TCRX TScan Therapeutics, Inc.
Accepted 2024-08-27 00:00:00 ET · period of report 2024-08-23 · accession 0000950170-24-101166 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-27 | 2024-08-23+ | TCRX | Klencke Barbara | Dir | P - Purchase | $5.61 | +10.0K | 35.0K | +40% | +$56.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Stock | 2024-08-26 | P | A | 5,000 | $5.53 | 40,000 | D | — | — | |
| 2 | Common | Voting Common Stock | 2024-08-23 | P | A | 5,000 | $5.69 | 35,000 | D | — | — |